Depressed Type 1 Cytokine Synthesis by Superantigen-Activated CD4 + T Cells of Women with Human Papillomavirus-Related High-Grade Squamous Intraepithelial Lesions

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 2, 2004, Pages 239-244

  Lee, Bang Ning ^a,b   Follen, Michele ^a,c   Shen, De Yu ^a   Malpica, Anais ^a   Adler Storthz, Karen ^b,d   Shearer, William T ^b   Reuben, James M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

ANTIGENS, BACTERIAL; CD8-POSITIVE T-LYMPHOCYTES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYTOKINES; ENTEROTOXINS; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; SUPERANTIGENS; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642326669     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.2.239-244.2004     Document Type: Article

References (25)

1. Auphan-Anezin, N., G. Verdeil, and A.-M. Schmitt-Verhulst. 2003. Distinct thresholds for CD8 T cells activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division. J. Immunol. 170: 2442-2448.
2. Bauer, H. M., Y. Ting, C. E. Greer, J. C. Chambers, C. J. Tashiro, J. Chimera, A. Reingold, and M. M. Manos. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
3. Berzofsky, J. A., J. D. Ahlers, M. A. Derby, C. D. Pendleton, T. Arichi, and I. M. Belyakov. 1999. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections. Immunol. Rev. 170:151-172.
4. Clerici, M., M. Merola, E. Ferrario, D. Trabattoni, M. L. Villa, B. Stefanon, D. J. Venzon, G. M. Shearer, G. De Palo, and E. Clerici. 1997. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J. Natl. Cancer Inst. 89:245-250.
5. + memory T cells. Int. Immunol. 9:1393-1403.
6. Garland, S. M. 2002. Human papillomavirus update with a particular focus on cervical disease. Pathology 34:213-224.
7. Garzetti, G. G., A. Ciavattini, G. Goteri, M. De Nicolis, S. Menso, M. Muzzioli, and N. Fabris. 1995. HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system. Gynecol. Obstet. Investig. 39:130-135.
8. Guijon, F. B., M. Paraskevas, and R. Brunham. 1985. The association of sexually transmitted disease with cervical intraepithelial neoplasia: A case control study. Am. J. Obstet. Gynecol. 151:185-190.
9. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, R. J. Kurman, and M. M. Manos. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
10. Johnson, J. C., A. F. Burnett, G. D. Willet, M. A. Young, and J. Doniger. 1992. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet. Gynecol. 79:321-327.
11. +, T cells in Staphylococcus enterotoxin B-primed mice. J. Exp. Med. 172:1065-1070.
12. Kruger-Kjaer, S., A. J. van den Brule, E. I. Svare, G. Engholm, M. E. Sherman, P. A. Pol, J. M. Walboomers, J. E. Bock, and C. J. Meijer. 1998. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int. J. Cancer 76:613-619.
13. Lee, B. N., M. Duvic, C.-K. Tang, C. Bueso-Ramos, Z. Estrov, and J. M. Reuben. 1999. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin. Diagn. Lab. Immunol. 6:79-84.
14. + T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions. Gynecol. Oncol. 75:379-386.
15. Mao, C., J. P. Hughes, N. B. Kiviat, J. Kuypers, S.-K. Lee, D. E. Adam, and L. A. Kousky. 2003. Clinical findings among young women with genital human papillomavirus infection. Am. J. Obstet. Gynecol. 188:677-684.
16. Moscicki, A.-B., N. Hills, S. Shiboski, K. Powell, J. Naomi, E. Hanson, S. Miller, L. Clayton, S. Farhat, J. Broering, T. Darragh, and J. Palefsky. 2001. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 285:2995-3002.
17. National Cancer Institute Workshop. 1989. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 262:931-934.
18. Passmore, J.-A. S., V. C. Burch, E. G. Shepherd, D. J. Marais, B. Allan, P. Kay, R. C. Rose, and A.-L. Williamson. 2002. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV. J. Med. Virol. 67:234-240.
19. Pilch, H., H. Hohn, C. Neukirch, K. Freitag, P. G. Knapstein, B. Tanner, and M. J. Maeurer. 2002. Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor. Clin. Diagn. Lab. Immunol. 9:267-278.
20. Rafiq, K., L. Charitidou, D. M. A. Bullens, A. Kasran, K. Lorre, J. L. Ceuppens, and S. W. Van Gool. 2001. Regulation of the IL-10 production by human T cells. Scand. J. Immunol. 53:139-147.
21. Rosini, S., S. Caltagirone, G. Tallini, G. Lattanzio, R. Demopoulos, M. Piantelli, and P. Musiani. 1996. Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infection. Hum. Pathol. 27:834-838.
22. Skov, L., J. Olsen, R. Giorno, P. Schlievert, O. Baadsgaard, and D. Leung. 2000. Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. J. Allergy Clin. Immunol. 105:820-826.
23. Takac, I. 1998. The frequency of bacterial and yeast infection in women with different grades of cervical intraepithelial neoplasia (CIN). Eur. J. Obstet. Gynecol. Reprod. Biol. 80:231-234.
24. Torres, L. M., T. Cabrera, A. Concha, M. R. Oliva, F. Ruiz-Cabello, and F. Carrido. 1993. HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix. Tissue Antigens 41:65-71.
25. Truneh, A., F. Albert, P. Golstein, and A. M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318-320.